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Abstract
Emergence of chronic ‘sterile’ inflammation during obesity in absence of overt infection or 
autoimmune process is a puzzling phenomenon. The Nod Like Receptor (NLR) family of innate 
immune cell sensors like the Nlrp3 inflammasome are implicated in recognizing certain non-
microbial origin ‘danger–signals’ leading to caspase-1 activation and subsequent IL-1β and IL-18 
secretion. We show that reduction in adipose tissue expression of Nlrp3 is coupled with decreased 
inflammation and improved insulin–sensitivity in obese type-2 diabetic patients. The Nlrp3 
inflammasome senses the lipotoxicity–associated ceramide to induce caspase-1 cleavage in 
macrophages and adipose tissue. Ablation of Nlrp3 prevented the obesity–induced inflammasome 
activation in fat depots and liver together with enhanced insulin–signalling. Furthermore, 
elimination of Nlrp3 in obesity reduced IL-18 and adipose tissue IFNγ along with an increase in 
naïve and reduction in effector adipose tissue T cells. Collectively, these data establish that Nlrp3 
inflammasome senses obesity–associated ‘danger–signals’ and contributes to obesity–induced 
inflammation and insulin–resistance.
Keywords
Inflammation; obesity; type 2 diabetes; IL-18; T cells; adipocytes; adipose tissue; macrophages; 
cryopyrin; Pycard; IL-1β; caloric restriction; caspase-1; Nlrp3; Nalp3; ASC; LPS; Ceramide; 
Lipotoxicity; MAPK; Akt
Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
6Address and Correspondence to: Vishwa Deep Dixit, Ph.D, Laboratory of Neuroendocrine-Immunology, Pennington Biomedical 
Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, Vishwa.Dixit@pbrc.edu, Phone: 225-763-2719, Fax: 225-763-0261. 
HHS Public Access
Author manuscript
Nat Med. Author manuscript; available in PMC 2011 August 01.
Published in final edited form as:














Despite no overt infection or auto–antigen mediated immune cell activation, the chronic 
inflammation during obesity is an established instigator of several diseases like the type 2 
diabetes, defective immunity, atherosclerosis, certain cancers, CNS dysfunction and 
dementia1–4. It is recognized that activation of adipose tissue macrophages and T cells 
within fat depots is coupled with the development of obesity–induced pro–inflammatory 
state and insulin resistance 5, 6. The activation of classically activated M1 macrophages at 
the expense of anti–inflammatory M2 macrophages has been causally linked to the 
development of adipose–tissue inflammation and metabolic syndrome7, 8, a 
pathophysiological state aptly termed as “metainflammation”9. It is recognized that several 
pro–inflammatory cytokines10, including IL-1β, are implicated in disrupting insulin–
signaling11. Consistent with these data, randomized clinical trials have demonstrated that 
blockade of Interleukin1β (IL-1β) signalling by Anakinra, a recombinant human IL-1 
receptor antagonist leads to sustained reduction in systemic inflammation and improvement 
of type-2 diabetes12, 13. However, the origin of inflammation during obesity and the 
underlying molecular mechanisms are not fully understood. Furthermore, although the 
physiological rationale of release of pro–inflammatory cytokines by macrophages during 
infection is established14, 15, the mechanism underlying the maladaptive chronic 
inflammation observed during adipose–tissue expansion and obesity is still speculative.
Innate immune cells such as macrophages discriminate infectious agents from self proteins 
by detecting ‘pathogen–associated molecular patterns’ (PAMPs) through expression of 
pattern–recognition receptors (PRRs), such as Toll–like receptors (TLRs) and Nod–like 
receptors (NLRs) 15–17. Emerging evidence suggests that macrophages can also recognize 
the injured or damaged–cell derived ‘danger–associated molecular patterns’ (DAMPs) and 
release pro–inflammatory cytokines such as IL-1β18–20. The release of bioactive IL-1β and 
IL-18 from macrophages is in turn dependent on autocatalytic activation of procaspase 1 
zymogen into enzymatically active 10 and 20 kDa caspase-1 heterodimers 21–23. The 
presence of a large N-terminal homotypic protein–protein interaction motif called caspase 
activation recruitment domain (CARD) is critical for formation of multiprotein scaffolds 
called inflammasome wherein caspase-1 undergoes conformational change required for its 
cleavage and full activation18–20, 24.
Structurally, the NLR proteins contain N-terminal CARD or pyrin domains needed for 
homotypic protein–protein interaction, an intermediate nucleotide binding self–
oligomerization NACHT domain and a C-terminal domain containing leucine–rich repeats 
(LRRs)18–20, 24. Among the NLR family members, the Nlrp3 inflammasome (for NACHT, 
LRR and pyrin domain containing protein) has been implicated in sensing the non–microbial 
origin DAMPs such as extracellular ATP, urate crystals, asbestos, silica and β-amyloid25–28. 
The assembly of the Nlrp3 inflammasome requires interaction of pyrin domain (PYD) of 
ASC (for apoptosis–associated speck like protein containing carboxy–terminal CARD) with 
PYD of Nlrp3, and a functional inflammasome complex is formed through CARD–CARD 
interaction of ASC with procaspase 124, 29.
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It has been shown that obesity–induced elevation in specific saturated free–fatty acids may 
activate the TLR4 mediated signalling in macrophages and participate in inducing insulin 
resistance30, 31. However, it remains unclear whether cytosolic PRRs such as Nlrp3 play a 
role in sensing obesity related ‘danger signals’ or if Nlrp3 inflammasome participate in 
immune dysfunction leading to chronic inflammation and insulin–resistance in diet–induced 
obesity. We show that Nlrp3 inflammasome activation in obesity promotes macrophage-T 
cell activation in adipose tissue and impairs insulin–sensitivity.
Results
Nlrp3 is associated with obesity–induced insulin resistance
Our initial studies evaluated the expression of IL-1β and Nlrp3 in the adipose tissue. These 
data show that in mice the mRNA expression of IL-1β and Nlrp3 in the visceral adipose 
tissue (VAT) was correlated with body weight and adiposity (Fig. 1a,b). The anti–thesis of 
obesity, calorie restriction (CR) extends lifespan, reduces inflammation and enhances insulin 
sensitivity32, therefore we examined whether CR impacts the inflammasome transcriptional 
machinery in fat depots. Compared to ad libitum (AL) chow fed control mice, chronic CR 
(40% reduction in food intake) in age–matched middle aged animals (12 month old) resulted 
in a significant reduction (P < 0.01) in Nlrp3, Asc and Il-1β mRNA in both visceral adipose 
tissue (VAT) and subcutaneous adipose tissue (SAT) (Fig. 1c–e) in parallel with reduction 
in fat cell size (Fig. 1f,g).
To test the clinical relevance of data generated from mouse models, we investigated the 
obese–type 2 diabetic mellitus (T2DM) patients before and after weight loss achieved by 
intensive behaviour modifications such as CR and exercise (Supplementary Table 1). The 
intervention was designed to achieve and maintain weight loss through decreased caloric 
intake and increased physical activity with an expected 1-year weight loss of ≥ 7% of the 
initial value33. The weight loss in obese–T2DM subjects resulted in significant reduction in 
fat cell size and improvement of insulin–sensitivity (Supplementary Table 1). We collected 
the abdominal SAT biopsies from obese–T2DM male Caucasian subjects (n = 10) before 
and after 1 year weight–loss intervention. To prevent observer bias, the real time PCR 
analysis to quantify the mRNA levels of NLRP3, ASC and IL-1β was performed in blinded 
fashion. The weight loss enhanced the insulin sensitivity in obese–T2DM which was 
associated with significant reduction in IL-1β and NLRP3 mRNA expression in SAT with no 
change in ASC (Fig. 1h). Of note, the reduction in IL-1β and NLRP3 expression in SAT was 
coupled with lower glycemia and the improvement in HOMA–IR in these subjects (Fig. 1i), 
(Supplementary Table 1). Together, these experiments in mouse models and humans 
indicate that increased adipose tissue Nlrp3 expression is correlated with obesity associated 
insulin–resistance. Conversely, chronic caloric restriction and weight–loss induced 
improvements in insulin–sensitivity is associated with reduction in adipose tissue expression 
of Nlrp3 inflammasome and IL-1β.
Nlrp3 inflammasome activation in obesity regulates IL-1β and IL-18
Nlrp3 is known to be present in several tissues and cell types34 but it is not known which 
cellular compartments in adipose tissue express the inflammasome components. The 
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immunostaining of adipose tissue sections of obese mice revealed strong co–localization of 
Nlrp3 with macrophage marker F4/80 (Fig. 2a) in crown–like structures (CLS). Consistent 
with immunofluorescence data, the examination of purified F4/80+ adipose tissue 
macrophages (ATMs), stromal vascular fraction (SVF) and mature 3T3L1 adipocytes 
revealed that both Nlrp3 and Asc are highly expressed in ATMs and SVF cells with low 
expression in adipocytes (Fig. 2b,c). We also analyzed the Nlrp3 expression in enriched 
primary adipocytes from adipose tissue. Normalization of Nlrp3 mRNA with differentiated 
macrophage marker Cd11c in adipocytes fraction revealed that almost all Nlrp3 expression 
in enriched primary adipocytes maybe be attributed to contaminating lipid engorged 
macrophages (data not shown).
Notably, the development of progressive adiposity in high–fat diet (HFD) fed mice led to 
strong caspase-1 auto activation in adipose tissue (Fig. 2d), (Supplementary Fig. 1a,b). 
Consistent with progressive caspase-1 activation in obesity, we found an increase in IL-1β 
processing in adipose tissue with highest expression in 9 month old diet–induced obese 
(DIO) mice (Fig. 2d). Since the highest caspase-1 activation was detected in 9 month old 
DIO mice (Fig. 2d), (Supplementary Fig. 2a) and high prevalence of obesity ‘epidemic’ and 
related co–morbidities in middle–age population, we next studied the role of Nlrp3 
inflammasome using chronic DIO model. This rationale is based on the hypothesis that 7 
months of HFD feeding is likely to induce a more severe disease than the 6–8 weeks of HFD 
feeding in mice. Furthermore, although it is established that Nlrp3 inflammasome regulates 
post–translational processing of caspase-1 in vitro in the bone marrow derived macrophages, 
specificity of this pathway in vivo in HFD induced obesity is not established. Of note, 
compared to healthy–lean mice, obesity led to marked increase in caspase-1 autoactivation 
in VAT, SAT and liver (Fig. 2e), (Supplementary Fig. 1). Ablation of Nlrp3 partially 
blocked the obesity induced caspase-1 autoactivation in VAT, SAT and liver (Fig. 2e), 
(Supplementary Fig. 1), but did not affect caspase-1 cleavage in kidney (Fig. 2f). These 
findings demonstrate that in obesity, caspase-1 is specifically activated in adipose tissue and 
liver through Nlrp3 inflammasome dependent mechanism but in kidney this process is 
independent of Nlrp3 and is tissue specific.
The post –translational processing of IL-1β is complex and can be regulated through several 
inflammasomes including Ipaf inflammasome, and AIM2 inflammasome19–20. Furthermore, 
pro–IL-1β can be processed through neutrophil–derived serine proteases in a caspase-1 and 
inflammasome independent fashion21, 35. Our data show that compared to wild type (WT) 
mice the ablation of Nlrp3 inflammasome reduced the expression of active IL-1β in adipose 
tissue of diet induced obese (DIO) mice (Fig. 2g), (Supplementary Fig. 2b). The chow fed 
WT mice and Nlrp3 deficient animals did not show a difference in IL-1β processing in VAT 
(data not shown). Notably, compared to chow fed mice, obesity was associated with 
significant increase in serum IL-18 concentrations which was blocked upon ablation of 
Nlrp3 (Fig. 2h). The serum levels of IL-1β in our WT and Nlrp3−/− mice were below the 
detection limit of the ELISA (data not shown). These data demonstrate that Nlrp3 
inflammasome is specifically activated in response to high fat diet and controls the 
production of IL-1β in adipose tissue and IL-18 in obesity.
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Nlrp3 inflammasome impairs insulin–sensitivity in obesity
To further understand the role of Nlrp3 inflammasome in regulating insulin–action, we 
performed insulin and glucose tolerance test (ITT and GTT) in WT and Nlrp3−/− mice fed 
HFD for 6 weeks, 4 months (6 month old) and 7 months (9 month old). The ITT and GTT 
revealed that in early stages of obesity, the elimination of Nlrp3 inflammasome affords 
greater protection against HFD–induced insulin–resistance (Fig. 3a). In chow fed controls, 
ablation of Nlrp3 did not alter insulin action (Supplementary Fig. 3a,b) nor affect glucose 
homeostasis suggesting specific activation of Nlrp3 inflammasome in diet–induced obesity. 
Compared to 6 month old WT DIO mice, Nlrp3−/− mice displayed higher magnitude of 
reduction in glucose after insulin injection (Fig. 3b,d) as well improved GTT (Fig. 3b). 
Furthermore, compared to age–matched controls, the 9 month old obese Nlrp3−/− mice (on 
HFD for 7 months) showed significant reduction in fasting glucose levels (Fig. 3c) as well 
as improved glucose homeostasis as revealed by the GTT (Fig. 3c). Due to lower baseline 
glucose values of Nlrp3−/− mice, the percent reduction in glucose post insulin injection was 
not significantly different. Estimation of area under the curve of ITT in 6 and 9 month old 
DIO mice demonstrated significant reduction in glucose levels in Nlrp3 deficient mice (Fig. 
3d).
Consistent with an association of Nlrp3 with adipocyte size and insulin–sensitivity in obese 
diabetic humans (Supplementary Table 1), the genetic ablation of Nlrp3 was associated with 
reduction in the fat cell size in VAT (Fig. 3e) but not in SAT (data not shown). Although the 
epidymal fat pad weight was lower in 3 month old DIO Nlrp3−/− mice, the final body 
weights of male WT and Nlrp3−/− mice on 60% HFD (or control chow) for 6 weeks, 4 
months and 7 months did not show significant differences (Supplementary Fig. 4a,b). We 
did not detect any change in blood triglycerides and cholesterol levels in middle–aged obese 
Nlrp3−/− mice (Supplementary Fig. 4c,d).
Given that metabolic effects of insulin action are dependent on P13K–AKT signalling, we 
investigated the serine473 phosphorylation of AKT after 5 and 10 min insulin injection in 8 
month old obese WT (n = 9) and Nlrp3−/− mice (n = 9). Consistent with higher insulin–
sensitivity, the Nlrp3 deficient mice had significantly greater (P < 0.05) AKT activity in 
VAT, SAT, liver and muscle compared to the insulin treated obese WT control animals (Fig. 
3f), (Supplementary Fig. 5), while, vehicle injected control mice did not show any AKT 
phosphorylation (Supplementary Fig. 6a). Consistent with enhanced insulin–sensitivity in 
the absence of Nlrp3 inflammasome, there was also a reduction in serine phosphorylation of 
IRS-1 in liver and fat of Nlrp3 deficient obese mice (Fig. 3f), (Supplementary Fig. 5e).
Apart from PI3K–AKT pathways, insulin can also signal by promoting the interaction of 
adaptor protein, Grb2 with son–of–sevenless to activate the Ras–MAPK signalling36. 
Considering that Ras–MAPK pathway primarily regulates non–metabolic effects of insulin 
such as cell growth, differentiation and survival36, we next tested the specificity of insulin–
signalling in Nlrp3 inflammasome deficient obese mice. Interestingly, compared to control 
animals, we found marked activation of Erks 1 and 2 MAPK specifically in the VAT but not 
in SAT, liver or muscle (Fig. 3f), (Supplementary Fig. 6b). These data suggest that 
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improvement of insulin–sensitivity in Nlrp3 deficient mice is related to overall stimulation 
of PI3K–AKT pathway while the MAPK pathways is selectively activated in visceral fat.
Considering a reduction in Nlrp3 inflammasome dependent caspase-1 activation in liver and 
improvement in insulin signalling, we also investigated hepatic steatosis in 9 month old DIO 
Nlrp3−/− mice. The histological evidence suggest that compared to WT mice, the ablation of 
Nlrp3 resulted in reduction in hepatic steatosis (Fig. 3g) which is consistent with recent 
findings that activation of Nlrp3 inflammasome induces hepatic fibrosis and liver injury37, 
38. Furthermore, the reduction in fatty liver disease in obese Nlrp3−/− mice was associated 
with increase in fatty acid oxidation regulators Ehhad, Cpt1a and Crat, with no change in 
Acc1 and Fas (data not shown), the genes that regulate fatty acid synthesis (Fig. 3h).
Ceramides activate Nlrp3 inflammasome and ATMs in obesity
Inhibition of obesity–induced caspase-1 activation and insulin–resistance in Nlrp3−/− mice 
prompted us to investigate whether the Nlrp3 inflammasome senses specific inducers that 
activate innate immune cells like macrophages. Recent evidence suggest that during 
progressive obesity, the development of adipose tissue fibrosis restricts the adipocyte 
expansion which may ultimately cause lipid spill–over and increases in tissue and 
circulating levels of free fatty acids and ectopic fat in several organs39. Since ATMs can 
scavenge lipids and generation of ceramide from fatty acids during obesity induces 
inflammation41–43, we tested whether Nlrp3 inflammasome senses ceramide. Bone marrow 
derived macrophages were primed with LPS to induce transcriptional activation of IL-1β, 
and secondary inflammasome activation signal was provided by ceramides established 
previously27. The immunoblot analysis revealed that together with the positive control (LPS
+ATP) exposure of wild type macrophages to ceramides, causes activation of caspase-1 
(Fig. 4a). Notably, ceramide induced caspase-1 activation is blocked in the absence of Nlrp3 
(Fig. 4a). Consistent with this data, we observed that ceramide–induced IL-1β secretion 
from macrophages was reduced in absence of Nlrp3 (Fig. 4b).
Next, we investigated the physiological relevance of these data and tested whether 
ceramides can induce caspase-1 activation within the adipose tissue. We cultured the 
epididymal adipose tissue explants from 9 month old WT–DIO and Nlrp3−/− DIO in 
presence of LPS and ceramides. The LPS priming and ceramide induced caspase-1 
activation was reduced in adipose tissue explants of Nlrp3 deficient mice (Fig. 4c). 
Considering that within the adipose tissue, the adipose–tissue macrophages (ATMs) highly 
express Nlrp3 inflammasome (Fig. 2b,c), we investigated whether reduction of Nlrp3–
mediated sensing of obesity–associated pro–inflammatory inducers impacts the ATM's pro–
inflammatory profiles in vivo. The ATMs were enriched from stromal vascular fraction 
(SVF) through positive selection from VAT and SAT of 9 month old control WT and 
Nlrp3−/− DIO mice. We found that loss of Nlrp3 function increased the expression of M2 
macrophage associated transcripts, Il-10 and Arg1 in SAT–ATMs but not in VAT 
macrophages (Fig. 4d). These results suggest that the obese Nlrp3−/− mice specifically retain 
M2–like macrophage phenotype in the inguinal SAT. In addition, we found that M1–
macrophage associated expression of Tnfα, Ccl20 and Cxcl11 were specifically reduced in 
the visceral fat derived ATMs but not in SAT macrophages (Fig. 4d). Also, the expression 
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of Il-10 was increased in whole SAT while Tnfα was reduced in obese Nlrp3 deficient 
animals (Supplementary Fig. 7). Compared to WT–obese mice, the ATMs derived from 
SAT of Nlrp3−/− obese animals showed lower Nos2 expression (Fig. 4d). Collectively, these 
data suggest that ablation of Nlrp3 protects from obesity–associated pro–inflammatory ATM 
activation.
Nlrp3 inflammasome regulates adipose tissue T cells in obesity
Together with macrophages, the expanded adipose tissue during obesity also harbors 
activated T cell populations which are thought to participate in local adipose tissue 
inflammation and insulin sensitivity44–46. Reduction in adipose inflammation and improved 
insulin–action due to Nlrp3 deficiency prompted us to investigate the adipose tissue 
macrophages and T cell subsets. We found that in VAT of 9 month old DIO mice, the loss 
of Nlrp3 function did not affect the frequency of M1 (F4/80+CD11c+CD206−) or M2 
(F4/80+CD11c−CD206+) adipose tissue macrophages (ATMs) (Fig. 5a). Notably, we 
observed reduced numbers of smaller cells (on FSC/SSC, Figure 5A lower panel) in gate 2 
of obese Nlrp3−/− mice. Gating of this population in SVF revealed that these cells are not 
ATMs as they lacked the expression of F4/80, CD11c and CD206.
Further examination of smaller cells in gate 2 within SVF revealed that in WT mice 
approximately 60% of these cells are T lymphocytes (Fig. 5b). Compared to WT controls, 9 
month old middle–aged Nlrp3 deficient mice did not show significant differences in the 
frequency of CD4 and CD8 cells (Fig. 5b). Furthermore, in middle–aged 9 month old obese 
mice, elimination of Nlrp3 inflammasome signalling did not affect the overall ratio (percent 
gated) of CD4 and CD8 effector-memory E/M (CD62L−CD44+) or CD4/CD8 naïve T cell 
subsets (CD62L+CD44−) (Fig. 5b). The ablation of Nlrp3 in 9 month old DIO mice reduced 
the overall percentage of lymphocytes (in FSC/SSC - Gate 2) within the SVF of VAT. The 
estimation of T cell numbers within SVF revealed that loss of Nlrp3 led to significant 
reduction in the overall numbers of CD4s, CD4 E/M cells, CD8s and CD8 E/M cells without 
significant difference in naïve T cells (Fig. 5c). Consistent with these data, Nlrp3 deficient 
obese mice had significant reduction in the total number of SVF cells in the visceral fat at 
both early (3 month old) and chronic stages of obesity (9 month old) (Fig. 5d).
Among various T cell subsets, the CD4+CD25+FoxP3+ T regulatory (Treg) cells constitute 
an important defence mechanism to dampen pro–inflammatory response in several 
autoimmune and infectious diseases44. Recent studies demonstrate that anti–inflammatory 
Treg cells in adipose tissue are reduced in obesity and increase in the Treg cell number 
improves insulin–action 44. Analysis of Treg cell in visceral fat (epididymal + perirenal), 
subcutaneous fat (inguinal) in middle–aged DIO mice revealed no significant differences 
between WT and Nlrp3 deficient mice (Fig. 5e,f) suggesting specificity of Nlrp3 dependent 
effects on adipose tissue effector T cell subsets.
Together with VAT, the SAT also constitutes a significant proportion of adipose mass in 
obese mice. Considering that obesity–associated caspase-1 autoactivation in SAT is Nlrp3 
dependent, we next investigated whether the reduction in macrophage activation and 
insulin–sensitivity is associated with changes in distribution of naive and effector/memory–
ART (adipose resident T cells) cell subsets in subcutaneous fat. Notably, elimination of 
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Nlrp3 inflammasome in 9 month old obese mice increased the number of M2 macrophages 
(F4/80+CD11c−CD206+) without affecting the M1 macrophage (F4/80+CD11c+CD206−) 
frequency (Fig. 6a,b). Surprisingly, compared to WT–obese mice, both the CD4/CD8 
adipose resident T cell number was significantly higher in Nlrp3−/− animals (Fig. 6c,d). 
Furthermore, examination of total CD4 and CD8 cells revealed that there was a 
preponderance of naïve cells (CD4+CD62L+CD44−, CD8+CD62L+CD44−) within the 
adipose T cell compartment of Nlrp3 deficient DIO mice (Fig. 6c,d) suggesting a lower 
inflammatory profile in fat.
Considering that macrophage–derived IL-18 induces a T helper1 (Th1) response for host 
defence against specific infections, we also investigated the classical Th1 derived cytokine 
IFNγ in context of ‘sterile’ obesity–induced inflammation in Nlrp3 deficient mice. 
Consistent with reduction in obesity–induced IL-18 in Nlrp3−/− mice (Fig. 2h), the ablation 
of Nlrp3 inflammasome lowered the expression of Ifnγ mRNA as well as protein in the 
adipose tissue during obesity (Fig. 6e,f). Furthermore, in absence of Nlrp3 inflammasome, 
obesity–induced increase in circulating interferon gamma inducible protein IP–10/CXCL10 
and MCP–1/CCL2 were significantly reduced (Fig. 6g) without any change in IL-17 levels 
(data not shown). Collectively, the data suggest that blocking the activation of Nlrp3 
inflammasome in response to obesity related ‘danger signals’ may lower macrophage-T cell 
interactions that participate in sustaining chronic inflammation (Fig. 6h).
Discussion
Obesity is associated with self–directed tissue inflammation where local or systemic factors 
other than infectious agents activate the cells of innate immune system. In addition, evidence 
that ‘sterile’ inflammation during obesity is because of underlying autoimmune processes or 
due to presence of organ specific auto–antibodies has so far not been demonstrated. 
Therefore, obesity–induced chronic low grade inflammation and the development of 
metabolic syndrome may qualify the established criterion of “autoinflammatory disease 
cluster” 47, 48. The influx of macrophages and T cells in adipose tissue upon chronic caloric 
excess driven obesity and release of pro–inflammatory mediators by these cells causes 
insulin–resistance6–9, 31. However, an upstream initiating event for obesity–induced 
immune cell activation in adipose tissue is not established. Here we demonstrate that Nlrp3 
inflammasome plays a substantial role in sensing obesity–associated inducers of caspase-1 
activation and therefore regulates the magnitude of the inflammation and its downstream 
effects on insulin signalling.
Our findings that adipose tissue expression of IL-1β and Nlrp3 is correlated with reduction 
in plasma glucose and insulin sensitivity in obese T2D patients post weight loss and 
reduction in Nlrp3 expression post CR in mice raised several questions. First, can caspase-1 
undergo autoactivation in obesity and whether eliminating the signalling through Nlrp3 
reduces adipose inflammation and improves insulin action? We found that induction of 
high–fat diet induced obesity caused marked caspase-1 activation in adipose tissue and liver. 
Such a steady state in vivo activation of caspase-1 in obesity has so far not been reported in 
the context of self–directed tissue inflammation. The loss of Nlrp3 function reduced but did 
not eliminate the caspase-1 activation in visceral fat, subcutaneous fat and liver suggesting 
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that other inflammasome may contribute in pathophysiology of obesity. In addition, Nlrp3 
inflammasome activation was tissue specific as obesity–induced caspase-1 activation in 
kidney was not affected in Nlrp3 deficient mice. Consistent with these data, obese Nlrp3−/− 
mice were more insulin sensitive.
Another question that emerges from our findings is what is being sensed by Nlrp3 
inflammasome to induce caspase-1 activation in obesity? This question is difficult to 
answer, particularly in a complex disorder such as diet–induced obesity where alterations in 
several cell–stress associated metabolites could potentially activate Nlrp3 or other 
inflammasomes (Fig. 6h). It has been shown that saturated fatty acids like oleate and 
palmitate can induce inflammation by TLR430 and loss of TLR4 function can partially 
protect against obesity induced insulin–resistance31. Notably, obesity–related increased 
levels of lipotoxic ceramides can induce cell death and also trigger inflammation. Our data 
demonstrates that ceramides induce caspase-1 activation in an Nlrp3 dependent mechanism. 
However, it is possible that several other inducers may participate in caspase-1 activation. 
For example Nlrp3 inflammasome has been recently shown to be activated by oxidized LDL 
and cholesterol crystals in models of high fat diet–induced atherogenesis leading to 
macrophage activation and IL-1β secretion49. Cells undergoing necrosis can also activate 
Nlrp3 inflammasome in macrophages50. Considering that the development of obesity is also 
associated with hypoxia51, 52 and adipocyte death53, it is likely that ATMs that form ‘Crown 
Like Structures’ can be activated via Nlrp3 sensing pathway. Thus, it is possible that 
reduced sensing of such ‘danger associated molecular patterns’ (DAMPs) due to Nlrp3 
deficiency protects from long–term obesity and hyperglycemia associated insult (Fig. 6h).
Lastly, another question that arises from our data is which mediators downstream of Nlrp3 
inflammasome participates in the mechanism of obesity–induced inflammation and insulin–
sensitivity? Although, the Nlrp3 inflammasome specifically regulates caspase-1 activation 
that allows the release of IL-1β and IL-18, both these cytokines in turn can initiate several 
events that may amplify inflammatory responses21. Our prior studies have found that obesity 
is associated with increase in IFNγ+ T cells in the adipose tissue 54. It is well known that 
IFNγ alone or together with microbial stimuli (such as LPS) is known to cause induction of 
classically activated M1 macrophages17. In context of obesity–associated inflammation, we 
provide additional mechanistic insight that reduction in IL-1 β and IL-18 processing is 
regulated by Nlrp3 inflammasome that may deliver secondary signals to adipose tissue T 
cells and induce an effector Th1 pro–inflammatory profile in adipose tissue. Consistent with 
our data of reduced IFNγ in Nlrp3−/− mice and improved insulin–signaling, the reduction in 
IFNγ is associated with improved metabolic outcomes in obesity 55. Furthermore, increases 
in M1 macrophage derived cytokines and effector T cells in adipose tissue are causally 
linked to insulin resistance 8, 45, 46. Together with our previous studies that show that 
purified adipose T cells produce several cytokines that further activate macrophages 54, our 
present data demonstrates that elimination of Nlrp3 inflammasome reduced M1–like 
macrophage gene expression and increases M2–like expressed cytokines. These data suggest 
that Nlrp3 inflammasome sensing pathway participate in the origin of inflammation in 
obesity by inducing macrophage and subsequent T cell activation (Fig. 6h).
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Notably, blocking the obesity–induced gain of Nlrp3 inflammasome function did not affect 
the Treg cell homeostasis in adipose tissue but specifically reduced the E/M cells and 
increased the naïve CD4 and CD8 T cell populations. Consistent with our data, reduction in 
E/M cells in VAT may be linked to decrease in CCL20 and CXCL11 chemokine 
expression56. The improvement in overall metabolic profiles upon elimination of Nlrp3 
signaling may also be related to lower hepatic steatosis and regulation of genes that control 
hepatic fatty acid oxidation in obese mice. During the preparation of our manuscript, it was 
reported that uric acid induced release of reactive oxygen species facilitate the interaction of 
thioredoxin interacting protein (TXNIP) to Nlrp3, leading to IL-1β release57. Consistent 
with our findings, these studies also support a role of Nlrp3 inflammasome in regulating 
glucose homeostasis57.
The early observations that pro–inflammatory mediator, TNFα induces insulin resistance in 
vitro and in mice, have so far yielded disappointing results in limited randomized clinical 
trials in obese T2DM patients 58. On the other hand, inhibiting IL-1β signaling by IL-1 
receptor antagonists Anakinra can dampen systemic inflammation including decrease in 
circulating C-reactive protein (CRP) and IL-6 and reduction in type 2 diabetes in humans 12, 
13. Furthermore, widely used anti–diabetic sulfonyl–urea drugs such as glyburide can also 
block Nlrp3 inflammasome activation and reduce mortality due to septic shock59. Taken 
together, our data establish that Nlrp3 inflammasome dependent post–translational 
processing of IL-1β and IL-18 in response to obesity–associated ‘danger signals’ participates 
in the development of chronic pro–inflammatory state which impairs insulin–sensitivity. 
These findings highlight the potential of targeting the molecular pathways regulating 




The participants (10 Caucasian males, obese, with type 2 diabetes) were examined to study 
the effects of 1-year intensive lifestyle intervention to promote weight-loss 33. The 
intervention was designed to achieve and maintain a weight loss of at least 7% through 
decreased caloric intake and increased physical activity. The inclusion and exclusion criteria 
have been previously described 33. We measured the fat mass in all subjects by dual-energy 
X-ray absorptiometry (Hologic QDR 4500A, Waltham, MA) and the analysis of fasting 
levels of glucose, FFA, insulin and adiponectin and HOMA – IR calculations were 
performed as described previously 12,33. We determined the insulin–stimulated glucose 
disposal rate using a euglycemic–hyperinsulinemic clamp (90 mg dl−1, 80 mU m2 min−1). 
The NLRP3 and IL1β mRNA in the abdominal subcutaneous adipose tissue was determined 
by quantitative Real Time PCR and cyclophilin B was as a house keeping gene. All studies 
were performed under an IRB approved protocol with informed consent from participants.
Mice and animal care
Nlrp3−/− mice have been described previously35. The mice were fed with ad libitum high-fat 
diet consisting of 60% calories from fat (D12492i; Research Diets Inc) starting at 8 weeks of 
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age and control mice with a standard chow diet consisting of 4.5% fat (5002; LabDiet). We 
purchased the 12 month female calorie restricted mice and ad libitum (AL) fed, C57/B6 
mice from NIA-aging rodent colony. We performed all experiments in compliance with the 
NIH Guide for the Care and Use of Laboratory Animals, which were approved by the 
Institutional Animal Care and Use Committee at Pennington Biomedical Research Center.
ITT and GTT test
We performed ITT and GTT on 4 hour fasted mice by giving an intraperitoneal injection of 
insulin (0.83 mU g−1 body weight, Sigma, USA) and D-glucose (1.8 mg g−1 body weight, 
Sigma, USA). Glucose levels in tail blood were measured using a glucometer (Breeze, 
Bayer Health Care, USA).
Preparation of SVF cells and adipose tissue macrophages isolation
The subcutaneous (inguinal fat pad) and visceral adipose tissue (epididymal fat pad) were 
digested as described previously54. We isolated the the macrophages from SVF cells by 
positive selection selected using anti-F4/80 antibody (eBiosciences), followed by biotin-
conjugated secondary rat IgG and cells were purified using streptavidin labelled magnetic 
beads (Dynabeads, Invitrogen).
Flow cytometry
We stained the SVF cells from specific adipose depots with anti-F4/80, CD206, and CD11c 
(eBiosciences and Biolegend) to indentify macrophage subsets. We labelled the T cell 
subpopulations in SVF with anti -CD4, CD8, CD25, CD62L, FoxP3 and CD44 
(eBiosciences) as described previously54. We conducted the FACS analysis using FACS 
Calibur (BD Pharmingen) and the FACS data was analyzed by post collection compensation 
using FlowJO (Treestar Inc) software.
Macrophage culture and cytokine analysis
We prepared the murine bone marrow derived macrophages (BMDM) and cultured them 
according to previously established protocols 26. We primed the BMDMs with 100 ng ml−1 
ultrapure LPS (E coli serotype 0111:B4; Sigma) and after 12 h, ATP was added in a control 
well (1 mM) and ceramides in treatment wells with final concentration 0.1 mM. The IL-1β 
levels in BMDM supernatants were measured by ELISA (eBioscience) and cell lysates were 
used for western blot analysis.
Adipose tissue explants culture
We prepared and cultured the adipose tissue explants from epididymal fat pad as described 
previously 58. After 24 h of the treatment with LPS and ceramides, we prepared the protein 
lysates from adipose explants and analysed them for caspase-1 activation by immunoblot 
analysis.
Immunohistochemistry
We formalin fixed and paraffin embedded the adipose tissue from mice and stained the 
tissue sections with haematoxylin and eosin. The immunofluorescence analysis of Nlrp3 and 
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F4/80 in adipose tissue sections was performed as described previously54 and images were 
acquired using a Zeiss 510 Meta multiphoton confocal microscope.
Cytokine measurement
We measured the levels of IL-1β (eBioscience) and IL-18 by ELISA (MBL, Japan) and the 
serum levels of IP10 and MCP-1 using milliplex bead assay (Millipore).
Quantitative Real-time PCR
We isolated the total RNA from human SAT biopsy tissue, mouse fat, liver and from 
positively selected macrophages using RNeasy Lipid Tissue Mini Kit (Qiagen). All samples 
were DNAse digested to remove potential genomic DNA contamination. We conducted the 
Quantitative Real-time PCR as described previously (BioRad)4, 54.
Western Blot Analysis
For insulin-signaling experiments, we collected the adipose tissue, liver, kidney and muscle 
(gastrocnemius) and snap froze them in liquid nitrogen 5 and 10 minutes after the 
intraperitoneal insulin (0.8 mU g−1 body weight) injections. We conducted the immunoblot 
analysis for AKT, IRS1 and MAPK as described previously 54. For caspase-1 cleavage, we 
collected the organs of lean and DIO mice from additional cohorts of mice and snap froze 
them for western blot analysis. The protein immune complexes were detected using specific 
fluorescent secondary antibodies conjugated with IRDye™800CW (Rockland) and 
membranes were imaged using Odyssey Infrared Imaging System (LI–COR Odyssey 
BLOT).
Statistical Analyses
We used a two–tailed Student's t test to determine significance in differences between 
genotypes or treatments; *P < 0.05 and P < 0.01, **P < 0.005 and P < 0.001. We expressed 
the results as the mean ± SEM or the mean ± SE. The differences between means and the 
effects of treatments were also analyzed by one–way ANOVA using Tukey's test (Sigma 
Stat), which protects the significance (P < 0.05) of all pair combinations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Reduction of Nlrp3 and IL-1β expression is associated with improvement of insulin-
sensitivity
Positive correlation of the visceral fat mRNA expression of (a) Il-1β and (b) Nlrp3 with 
body weight of C57BL/6 mice (n = 32), Pearson's correlations are r = 0.364, P = 0.0178 for 
Il-1β and r = 0.672, P < 0.0001 for Nlrp3 respectively. (c) Il-1β, (d) Nlrp3 and (e) Asc 
mRNA in visceral and subcutaneous adipose tissue from AL fed control and calorie 
restricted 12 month old mice, n = 6; *P < 0.01, ** P < 0.005. Representative H&E staining 
showing adipocyte size in (f) visceral and (g) subcutaneous fat tissue from AL fed control 
and calorie restricted 12 month old C57BL/6 mice. (h) IL-1β (left) and NLRP3 (middle) and 
ASC (right) gene expression, as examined by qRT-PCR in human SAT in obese T2D 
patients before and after 1-year weight loss. (i) Positive correlation of changes in gene 
expression of IL-1β and NLRP3 in human abdominal subcutaneous fat with changes in 
fasting glucose level from baseline to 1-year post intervention; Pearson's correlations are r = 
0.53, P = 0.12 for IL-1β and r = 0.69, P = 0.03 for NLRP3 respectively. Relative gene 
expression levels are depicted as means ± SEM. n = 10; *P < 0.01, **P < 0.001. All samples 
analyses were performed in a blinded fashion.
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Figure 2. Elimination of Nlrp3 signaling prevents obesity induced caspase-1 cleavage and IL-1β/
IL-18 activation
(a) Immunofluorescent staining of epididymal fat (eFat) tissue sections stained with 
antibodies against F4/80 (red), and Nlrp3 (green). Merge of images with nuclear stain DAPI 
shows co–localization of Nlrp3 with ATM (yellow arrow heads). Negative control staining 
with addition of antibody to Nlrp3 together with antibody to F4/80 in adipose tissue of 
Nlrp3−/− mice displayed reduced Nlrp3 specific immunostaining. (b-c) Quantitative real 
time–PCR analysis of Nlrp3 and Asc mRNA in purified ATM, SVF derived from SAT and 
VAT of 6 month old DIO mice and mature 3T3L1 adipocytes (Adip). (d) Immunoblot 
analysis showing kinetics of caspase-1 (p20) cleavage and active IL-1β (p17) in adipose 
tissue of mice at different stages of diet–induced obesity. (e) Western blot analysis of 
activated caspase-1 (p20) in VAT, SAT and liver tissues from 9 month old DIO–WT 
(C57BL/6) and DIO– Nlrp3−/− mice. Results shown are representative of three independent 
experiments. (f) Western blot analysis of activated caspase-1 (p20) in kidney from 9 month 
old DIO–WT and DIO – Nlrp3−/− mice. (g) Western blot analysis of IL-1β activation in 
adipose tissue of 6 and 7 month old DIO mice. (h) Serum IL-18 concentration in age–
matched WT and Nlrp3−/− mice fed chow and 60% HFD for 4 months (6 month old DIO) 
and 7 months (9 month old DIO). All data are presented as means ± SEM, n = 6–10 mice; 
*P < 0.05.
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Figure 3. Nlrp3 inflammasome regulates insulin–sensitivity and steatohepatitis in obesity
(a) Insulin tolerance test (ITT) and glucose tolerance test (GTT) in male WT and Nlrp3−/− 
DIO mice fed 60% HFD for 6 weeks. (b) The ITT and GTT in 6 month and (c) 9 month old 
WT and Nlrp3−/− DIO mice. The ITT graphs display the area under the curve (green for WT 
and blue for Nlrp3−/−) with trend lines (n = 5–7 per group). (d) The total area under the 
curve for ITT in 6 and 9 month old WT and Nlrp3−/− DIO mice. (*P < 0.01). (e) Adipocyte 
size in visceral fat tissue from 8 month old DIO–WT (Nlrp3+/+) and Nlrp3−/− mice 
(hematoxylin and eosin staining). The cross–sectional size (area, μM2) of adipocytes (100 
cells per mouse) were determined in VAT using Image J software. Representative 
micrographs and the quantified results are shown. n = 6; *P < 0.001. (f) Akt, IRS-1 and 
MAPK signaling in vivo as determined by western blotting in VAT, SAT, liver, and muscle 
from the 8 month old DIO Nlrp3+/+ and DIO Nlrp3−/− mice. (g) Immunohistochemistry 
(hematoxylin and eosin staining) of section from liver tissues from 9 month old DIO WT 
and Nlrp3−/−. (h) Fatty acid oxidation and fatty acid synthesis gene expression in liver tissue 
of Nlrp3+/+ and Nlrp3−/− mice analyzed by quantitative RT–PCR. ΔΔCt of the genes are 
shown means ± SEM. (n = 5), * P < 0.05, **P < 0.001.
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Figure 4. Nlrp3 senses ceramide to induce IL-1β and regulates adipose tissue macrophage 
activation in obesity
(a) Western blot analysis of a large (∼20kD) catalytic subunits of caspase-1 in BMDM from 
Nlrp3+/+ and Nlrp3−/− mice (n = 6–9). The BMDMs were primed with LPS and treated with 
C2 Ceramide (100 μM). (b) IL-1β secretion in BMDM culture supernatants determined by 
ELISA. Results are representative of three separate experiments. (c) Epididymal adipose 
tissue (eAT) explants from 9 month old Nlrp3+/+ and Nlrp3−/− DIO mice were cultured for 
24h in presence of LPS and/or ceramides. Caspase-1 activation was determined by 
immunoblot analysis (d) M1 and M2 associated gene expression, was examined by qRT–
PCR in macrophages originating from VAT and SAT of 9 month old DIO–Nlrp3+/+ and 
DIO– Nlrp3−/− mice. The mRNA expression was normalized to Gapdh and shown as fold 
change (ΔΔCt). All data are presented as means ± SEM mean, *P < 0.01, **P < 0.001.
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Figure 5. Ablation of Nlrp3 inflammasome reduces adipose tissue effector T cells without 
affecting Treg cells in visceral fat of obese mice
(a) The FACS plot of SVF cells isolated from VAT of 9 month old WT and Nlrp3−/− obese 
mice. First dot plots depict Forward and side scatter (FSC/SSC) and gating strategy for 
analysis of ATMs and T cells. Gate1 (upper panel) of larger cells shows presence of F4/80+ 
cells (histogram) and expression of macrophage markers CD206 and CD11c on ATMs. 
Gating of smaller cells (gate 2, lower panel) reveals absence of ATMs in this population of 
SVF. (b) The gate 2 (lymphoid gate) presenting CD4, CD8 T cells in SVF. CD4 and CD8 
cells were evaluated for naïve T cells (CD62L+CD44−, blue box) and effector memory E/M 
(CD62L−CD44+, red box) CD4 and CD8 T cells. The FACS analysis was repeated in three 
independent pooled SVF fractions from a total of 12-14 mice. (c) Gated percentage and 
absolute numbers (in million cells) of naïve (CD62L+CD44−) and E/M (CD62L−CD44+) 
CD4 and CD8 T cells. (d) Number of stromal vascular cells per gram of fat tissue (n = 4–6) 
in 3 and 9 month old WT and Nlrp3−/− DIO mice. (e) Representative FACS plots showing 
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CD4+CD25+Foxp3+ T regulatory cells in VAT of 9 month old WT and Nlrp3−/− DIO mice. 
(f) Gated percentage of Treg cells in VAT and SAT of 9 month old WT and Nlrp3−/− DIO 
mice (n = 6 per group). All data are presented as means ± SEM mean, *P < 0.05.
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Figure 6. Elimination of Nlrp3 inflammasome reduces obesity–induced macrophage-T cell 
activation in adipose tissue
(a) The representative FACS plots of SVF cells from SAT of 6 month and 9 month old WT 
and Nlrp3−/− DIO mice stained with CD206 and CD11c. (b) The gated percentage of 
CD11c−CD206+ M2 cells in SAT of 9 month old obese mice. (c) Dot plots showing naive 
(CD62L+CD44−, blue box) and effector memory (CD62L−CD44+, red box) CD4 and CD8 T 
cells in SVF from 9 month old obese WT and Nlrp3−/− mice. (d) Gated percentage and 
absolute numbers (in million cells) of naïve (CD62L+CD44−) and effector memory 
(CD62L−CD44+) CD4 and CD8 T cells. (e) mRNA level of Th1 cytokine Ifnγ in VAT and 
SAT of 9 month old obese WT and Nlrp3−/− mice as determined by quantitative RT–PCR. 
(f) IFNγ (19kD) in VAT of 9 month old WT and Nlrp3−/− DIO mice as examined by 
western blotting. (g) IP10/CXCL10 and MCP–1/CCL2 levels in the serum of 9 month old 
lean WT and obese WT and Nlrp3−/− mice (n = 5). The data shown are mean ± SEM and *, 
P < 0.05. (h) Hypothetical model of Nlrp3 inflammasome activation in obesity. In absence 
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of ‘danger signals’ in healthy lean state, the tissue resident macrophages and T cells may 
participate in the maintenance of adipose tissue function. Nlrp3 inflammasome senses the 
obesity–associated ‘danger signals’ such as ceramides leading to caspase-1 autoactivation 
and IL-1β and IL-18 production from ATMs. Secondary signals from activated ATMs to 
effector adipose T cells sustain the reciprocal proinflammatory feed–forward cascade in 
obesity leading to insulin–resistance.
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